The Effect of Mid-urethral Sling on the Urethral Dynamic Shape and Motion

Sponsor
NorthShore University HealthSystem (Other)
Overall Status
Recruiting
CT.gov ID
NCT04843995
Collaborator
(none)
150
1
23.6
6.3

Study Details

Study Description

Brief Summary

The purpose of this prospective cohort study is to investigate the effect of sling on urethral dynamic shape and motion using static and dynamic pelvic floor ultrasound and additionally compare the findings among women with successful vs failed surgical outcome.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Mid-urethral sling

Detailed Description

This study is designed as a prospective cohort study. Our hypothesis is that mid-urethral sling provides backstop for excessive "swing motion" of distal urethra and helps with urethral compression along its luminal axis.

Aim 1: Investigate the effect of mid-urethral sling on the urethral shape at rest and maximum Valsalva, in other words dynamic urethral shape.

Aim 2: Compare the effect of mid-urethral sling on urethral dynamic shape in women with successful surgical outcome (absence of stress urinary incontinence at 3 and 12 months after the surgery) and women with surgical failure (presence of stress urinary incontinence at 3 and 12 months after the surgery).

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Effect of Mid-urethral Sling on the Urethral Dynamic Shape and Motion
Actual Study Start Date :
Jan 11, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Outcome Measures

Primary Outcome Measures

  1. Urethral Shape at 3 months [3 months]

    Urethral shape measured by ultrasound

  2. Urethral Motion at 3 months [3 months]

    Urethral motion measured by ultrasound

  3. Urethral Shape at 12 months [12 months]

    Urethral shape measured by ultrasound

  4. Urethral Motion at 12 months [12 months]

    Urethral motion measured by ultrasound

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Inclusion Criteria:
  • stress urinary incontinence interested in treatment with mid-urethral sling

  • able to consent in english and come to post-operative and research visits

Exclusion Criteria:
  • contraindication to mid-urethral sling

  • detrusor overactivity > 40cm H2O

  • post-void residual > 150mL

  • Maximum urethral closure pressure < 40 cm H2O

Contacts and Locations

Locations

Site City State Country Postal Code
1 NorthShore University HealthSystem Skokie Illinois United States 60076

Sponsors and Collaborators

  • NorthShore University HealthSystem

Investigators

  • Principal Investigator: Joel D Winer, MD, NorthShore University HealthSystem
  • Study Chair: Ghazaleh Rostami Nia, MD, NorthShore University HealthSystem

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
NorthShore University HealthSystem
ClinicalTrials.gov Identifier:
NCT04843995
Other Study ID Numbers:
  • EH21-027
First Posted:
Apr 14, 2021
Last Update Posted:
Apr 14, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 14, 2021